Quick View: Grail Is Progressing On Clinical Trials For Its Multi Cancer Test But Antitrust Challenges Continue
Medical Devices / United States / Wed 22 Nov, 2023
The Latest: On November 20 2023, Grail announced that it will initiate the Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH) study, which aims to assess the clinical impact of the Galleri multi-cancer early detection (MCED) test among Medicare beneficiaries in the US. This announcement comes after the FDA approved